CTS vs Knowles
CTS and KN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTS and KN compare
Knowles is the larger company, worth 1.6 times as much as CTS ($2.9B against $1.8B).
On earnings, CTS is cheaper: it trades at 24.5× trailing earnings, against 41.2× for Knowles.
Knowles grew revenue faster over the last twelve months (16.1% versus 7.6% for CTS).
CTS keeps more of each dollar of sales as profit, with a net margin of 12.9% compared with 10.8% at Knowles.
CTS pays a dividend yielding 0.26%; Knowles does not pay one.
CTS scores higher on the StockData Score (18 against 10 for Knowles), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTS | KN |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $2.9B |
| Share price | $62.07 | $33.81 |
| Change, 1 year | 50.3% | 49.4% |
| Change, 5 years | 65.5% | 53.3% |
| Beta (5Y) | 0.97 | 1.27 |
| Employees | 3,820 | 5,200 |
| StockData Score | ||
| Total score | 18 (better) | 10 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 | 3 |
| Performance score | 5 (better) | 4 |
| Health score | 3 | 3 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 24.5× (better) | 41.2× |
| P/S | 3.1× (better) | 4.3× |
| P/B | 3.0× (better) | 3.6× |
| EV/EBITDA | 12.3× (better) | 21.7× |
| P/FCF | 16.3× | – |
| PEG | 4.24 | – |
| FCF yield | 6.1% | – |
| Fair value | $68.27 | $28.07 |
| Margin of safety | 9.1% (better) | −20.4% |
| Growth | ||
| Revenue growth (TTM) | 7.6% | 16.1% (better) |
| Revenue growth, 5Y average | 5.0% (better) | −4.9% |
| Net income growth (TTM) | 29.2% | 71.9% (better) |
| EPS growth (TTM) | 33.2% | 70.8% (better) |
| EPS growth, 5Y average | 15.6% | 48.2% (better) |
| Profitability | ||
| Gross margin | 40.6% | 44.4% (better) |
| Operating margin | 17.0% (better) | 14.6% |
| Net margin | 12.9% (better) | 10.8% |
| FCF margin | 19.0% | – |
| Return on equity | 13.0% (better) | 9.3% |
| Return on invested capital | 14.7% (better) | 9.6% |
| Financial health | ||
| Debt / equity | – | 0.15 |
| Net debt / EBITDA | – | 0.51 |
| Interest coverage | 32.9× | – |
| Current ratio | 2.59 | 2.94 (better) |
| Altman Z-score | 7.19 (better) | 6.69 |
| Piotroski F-score | 8 | – |
| Dividends and buybacks | ||
| Dividend yield | 0.26% | – |
| Payout ratio | 6.2% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 1.8% | 2.0% (better) |
| Shareholder yield | 2.1% (better) | 2.0% |
| Ownership | ||
| Held by institutions | 98.9% | 103% |
| Held by insiders | 6.7% | 2.2% |
| Insider net buying, 12 months | −$9.8M (better) | −$24.4M |
| Short interest, % of float | 4.2% | 4.5% |
Go deeper
- CTS stock overview
- CTS income statement
- CTS valuation and score
- KN stock overview
- KN income statement
- KN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.